Surrozen, Inc. Common

R$126.36
BRL
Last updated on --.
24h volume2.00
24h highest125.04 BRL
24h lowest101.72 BRL
24h Price movement+1.18%

SRZN recent prices

24 Hours
+1.18%+R$1.474
30 days
-23.84%-R$39.55
60 days
-9.27%-R$12.92
90 days
-8.06%-R$11.09

Key data

Previous close124.89 BRL
Market cap1.55B BRL
Volume2.00
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-157.83 BRL
Net income (FY)-1.74B BRL
Revenue (FY)38.09M BRL
Last report dateMay 6, 2026

About Surrozen, Inc. Common

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
HeadquartersSOUTH SAN FRANCISCO
Employees (FY)44.00
Revenue per employee (FY)865.73K BRL
Net income per employee (FY)-39.57M BRL
Listed onNasdaq
Official website

SRZN conversion tables

SRZNSRZN
BRLBRL
0.5 SRZN63.18 BRL
1 SRZN126.36 BRL
5 SRZN631.81 BRL
10 SRZN1,263.63 BRL
BRLBRL
SRZNSRZN
0.5 BRL0.0039568 SRZN
1 BRL0.0079137 SRZN
5 BRL0.039568 SRZN
10 BRL0.079137 SRZN

FAQ

SRZN is trading at R$126.36, +1.18% over the last 24 hours. Track live moves on the price chart at the top of this page.
The SRZN stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. SRZN is currently trading at R$126.36, +1.18% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on SRZN price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. SRZN's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from SRZN; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against SRZN's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Surrozen, Inc. Common's market cap is currently 1.55B BRL. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume2.00
24h highest125.04 BRL
24h lowest101.72 BRL
24h Price movement+1.18%
SRZNSRZN
BRLBRL
Start trade with SRZN Perpetual